Hamman-Rich syndrome

Revision as of 15:47, 9 August 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Template:DiseaseDisorder infobox

WikiDoc Resources for Hamman-Rich syndrome

Articles

Most recent articles on Hamman-Rich syndrome

Most cited articles on Hamman-Rich syndrome

Review articles on Hamman-Rich syndrome

Articles on Hamman-Rich syndrome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hamman-Rich syndrome

Images of Hamman-Rich syndrome

Photos of Hamman-Rich syndrome

Podcasts & MP3s on Hamman-Rich syndrome

Videos on Hamman-Rich syndrome

Evidence Based Medicine

Cochrane Collaboration on Hamman-Rich syndrome

Bandolier on Hamman-Rich syndrome

TRIP on Hamman-Rich syndrome

Clinical Trials

Ongoing Trials on Hamman-Rich syndrome at Clinical Trials.gov

Trial results on Hamman-Rich syndrome

Clinical Trials on Hamman-Rich syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hamman-Rich syndrome

NICE Guidance on Hamman-Rich syndrome

NHS PRODIGY Guidance

FDA on Hamman-Rich syndrome

CDC on Hamman-Rich syndrome

Books

Books on Hamman-Rich syndrome

News

Hamman-Rich syndrome in the news

Be alerted to news on Hamman-Rich syndrome

News trends on Hamman-Rich syndrome

Commentary

Blogs on Hamman-Rich syndrome

Definitions

Definitions of Hamman-Rich syndrome

Patient Resources / Community

Patient resources on Hamman-Rich syndrome

Discussion groups on Hamman-Rich syndrome

Patient Handouts on Hamman-Rich syndrome

Directions to Hospitals Treating Hamman-Rich syndrome

Risk calculators and risk factors for Hamman-Rich syndrome

Healthcare Provider Resources

Symptoms of Hamman-Rich syndrome

Causes & Risk Factors for Hamman-Rich syndrome

Diagnostic studies for Hamman-Rich syndrome

Treatment of Hamman-Rich syndrome

Continuing Medical Education (CME)

CME Programs on Hamman-Rich syndrome

International

Hamman-Rich syndrome en Espanol

Hamman-Rich syndrome en Francais

Business

Hamman-Rich syndrome in the Marketplace

Patents on Hamman-Rich syndrome

Experimental / Informatics

List of terms related to Hamman-Rich syndrome


Hamman-Rich syndrome (also known as acute interstitial pneumonia) is a rare, severe lung disease which usually affects otherwise healthy individuals.

HR syndrome is often categorized as both an interstitial lung disease and a form of acute respiratory distress syndrome (ARDS).

Symptoms

The most common symptoms of Hamman-Rich syndrome are cough, fever, and difficulties breathing. These often occur over a period of one to two weeks before medical attention is sought. Difficulties breathing can quickly progress to an inability to breathe without support (respiratory failure).

Hamman-Rich syndrome typically progresses rapidly, with hospitalization and mechanical ventilation often required only days to weeks after initial symptoms of cough, fever, and difficulties breathing develop.

Diagnosis

Rapid progression from initial symptoms to respiratory failure is a key feature of Hamman-Rich syndrome. An x-ray which shows ARDS is necessary for diagnosis (fluid in the small air sacs (alveoli) in both lungs). In addition, a biopsy of the lung which shows organizing diffuse alveolar damage is required for diagnosis. Other diagnostic tests are useful excluding other similar condition, but history, x-ray, and biopsy are necessary. These other tests may include basic blood work, blood cultures, and bronchoalveolar lavage.

Treatment

Treatment of HR syndrome is primarily supportive. Management in an intensive care unit is required and the need for mechanical ventilation is common. Therapy with corticosteroids is generally attempted, though their usefulness has not been established as of 2005.

Epidemiology

HR syndrome occurs most frequently among people older than forty years old. It affects men and women equally. There are no known risk factors; in particular, smoking is not associated with increased risk.

Prognosis

Sixty percent of people with HR syndrome will die in the first six months of illness. However, most people who have one episode do not have a second. People who survive often recover lung function completely.

History

HR syndrome was first described in 1935 by Louis Hamman and Arnold Rich.

References

  1. ^ HR, AR. Fulminating diffuse interstitial fibrosis of the lungs. Trans Am Clin Climatol Assoc 1935; 51:154.

External links

Template:Respiratory pathology

de:Akute interstitielle Pneumonie


Template:WikiDoc Sources